PROCEPT BioRobotics (PRCT) Share-based Compensation (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Share-based Compensation data on file, last reported at $13.1 million in Q1 2026.

• Quarterly Share-based Compensation rose 29.32% year-over-year to $13.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.6 million (up 41.68% YoY) and the FY2025 annual result came in at $47.6 million, up 49.51% from the prior year.
• Share-based Compensation grew to $13.1 million in Q1 2026 per PRCT's latest filing, from $10.8 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $14.5 million in Q3 2025 and bottomed at $1.6 million in Q1 2022.
• The 5-year median for Share-based Compensation is $6.3 million (2024), against an average of $7.2 million.
• The widest annual swing landed in 2022, when Share-based Compensation jumped 269.1%; it then increased 19.34% in 2025.
• Tracing PRCT's Share-based Compensation over 5 years: stood at $2.9 million in 2022, then jumped by 72.65% to $5.0 million in 2023, then jumped by 82.39% to $9.1 million in 2024, then climbed by 19.34% to $10.8 million in 2025, then rose by 20.57% to $13.1 million in 2026.
• Per Business Quant, the three latest PRCT Share-based Compensation figures stand at $13.1 million (Q1 2026), $10.8 million (Q4 2025), and $14.5 million (Q3 2025).

Peer Comparison